Recent Material Events - Telik, Inc (TELK)

Filing Date	Description
2008-08-05	Dr. Ryser has served on the Company’s Board of Directors since September 1998. From April 2000 to July 2008, Dr. Ryser served as a managing partner at Bear Stearns Health Innoventures L.P., a venture capital fund, and as a managing director of B ...
2007-12-14	The foregoing summary of the changes is qualified in its entirety by the Amended and Restated Bylaws, which are attached hereto as Exhibit 3.2 and are incorporated herein by reference. ...
2007-02-22	The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2... ...
2007-02-14	On February 12, 2007, the Board of Directors of Telik, Inc. (the “Company”) committed to a restructuring plan that will result in an immediate reduction of approximately 25% of the Company’s workforce. Employees directly affected by th... ...
2006-12-26	On December 26, 2006, Telik, Inc. announced preliminary results from three separate Phase 3 clinical trials of its investigational drug TELCYTA. The foregoing description is qualified in its entirety by reference to Telik’s press release dated D... ...
2006-12-12	On December 11, 2006, Telik, Inc. (the “Company”) and Eastbourne Capital Management, L.L.C. and certain related persons and entities (collectively “Eastbourne ”) amended and restated the agreement (the “Amended and Restated St... ...
2006-11-06	On November 6, 2006, Telik, Inc. publicly disseminated a press release announcing certain financial results for the quarter ended September 30, 2006. The foregoing description is qualified in its entirety by reference to Telik’s press release da... ...